title: Would a CYP2B6 test help HIV patients being treated with efavirenz?
authors.forename: Chonlaphat
authors.initials: C
authors.lastname: Sukasem
authors.forename: Somnuek
authors.initials: S
authors.lastname: Sungkanuparph
mesh_terms: D000480:Alkynes; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D048588:Benzoxazines / Q000008:administration & dosage* / Q000009:adverse effects; D002490:Central Nervous System / Q000187:drug effects; D003521:Cyclopropanes; D065702:Cytochrome P-450 CYP2B6; D064420:Drug-Related Side Effects and Adverse Reactions; D005838:Genotype; D006678:HIV / Q000187:drug effects / Q000472:pathogenicity; D015658:HIV Infections / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D016896:Treatment Outcome
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D001189:Aryl Hydrocarbon Hydroxylases; C585599:CYP2B6 protein, human; D065702:Cytochrome P-450 CYP2B6; C098320:efavirenz